Literature DB >> 27710839

Environmental control of autoimmune inflammation in the central nervous system.

Veit Rothhammer1, Francisco J Quintana2.   

Abstract

Multiple sclerosis (MS) is a chronic autoimmune inflammatory demyelinating disorder of the central nervous system (CNS), which causes severe disability and requires extensive medical attention and treatment. While the infiltration of pathogenic immune cells into the CNS leads to the formation of inflammatory lesions in its initial relapsing-remitting stage, late stages of MS are characterized by progressive neuronal loss and demyelination even without continued interaction with the peripheral immune compartment. Several genetic and environmental factors modulate and influence these processes on multiple levels. Genetic variants confer a predisposition for the development of MS, but are not accessible to therapeutic intervention as of today. However, migration studies suggest that environmental factors influence disease development, activity and progression. This article reviews mechanisms of disease pathogenesis in MS and their modulation by environmental factors such as geographical localization, the gut microbiome and the diet. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27710839      PMCID: PMC5125858          DOI: 10.1016/j.coi.2016.09.002

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  73 in total

Review 1.  Why does the north-south gradient of incidence of multiple sclerosis seem to have disappeared on the northern hemisphere?

Authors:  Nils Koch-Henriksen; Per Soelberg Sorensen
Journal:  J Neurol Sci       Date:  2011-10-07       Impact factor: 3.181

Review 2.  Individual and joint action of environmental factors and risk of MS.

Authors:  I A F van der Mei; S Simpson; J Stankovich; B V Taylor
Journal:  Neurol Clin       Date:  2011-05       Impact factor: 3.806

Review 3.  Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses.

Authors:  Lazaros Belbasis; Vanesa Bellou; Evangelos Evangelou; John P A Ioannidis; Ioanna Tzoulaki
Journal:  Lancet Neurol       Date:  2015-02-04       Impact factor: 44.182

4.  Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract.

Authors:  Ivan Monteleone; Angelamaria Rizzo; Massimiliano Sarra; Giuseppe Sica; Pierpaolo Sileri; Livia Biancone; Thomas T MacDonald; Francesco Pallone; Giovanni Monteleone
Journal:  Gastroenterology       Date:  2011-04-16       Impact factor: 22.682

Review 5.  Vitamin D and multiple sclerosis: epidemiology, immunology, and genetics.

Authors:  Kelly C Simon; Kassandra L Munger; Alberto Ascherio
Journal:  Curr Opin Neurol       Date:  2012-06       Impact factor: 5.710

6.  Beta-lactam antibiotics modulate T-cell functions and gene expression via covalent binding to cellular albumin.

Authors:  Felix Mor; Irun R Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

7.  Fecal microbiota in early rheumatoid arthritis.

Authors:  Jussi Vaahtovuo; Eveliina Munukka; Mika Korkeamäki; Reijo Luukkainen; Paavo Toivanen
Journal:  J Rheumatol       Date:  2008-06-01       Impact factor: 4.666

8.  Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22.

Authors:  Teresa Zelante; Rossana G Iannitti; Cristina Cunha; Antonella De Luca; Gloria Giovannini; Giuseppe Pieraccini; Riccardo Zecchi; Carmen D'Angelo; Cristina Massi-Benedetti; Francesca Fallarino; Agostinho Carvalho; Paolo Puccetti; Luigina Romani
Journal:  Immunity       Date:  2013-08-22       Impact factor: 31.745

Review 9.  Incidence and prevalence of multiple sclerosis in Europe: a systematic review.

Authors:  Elaine Kingwell; James J Marriott; Nathalie Jetté; Tamara Pringsheim; Naila Makhani; Sarah A Morrow; John D Fisk; Charity Evans; Sarah Gabrielle Béland; Sophie Kulaga; Jonathan Dykeman; Christina Wolfson; Marcus W Koch; Ruth Ann Marrie
Journal:  BMC Neurol       Date:  2013-09-26       Impact factor: 2.474

10.  Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor.

Authors:  Veit Rothhammer; Ivan D Mascanfroni; Lukas Bunse; Maisa C Takenaka; Jessica E Kenison; Lior Mayo; Chun-Cheih Chao; Bonny Patel; Raymond Yan; Manon Blain; Jorge I Alvarez; Hania Kébir; Niroshana Anandasabapathy; Guillermo Izquierdo; Steffen Jung; Nikolaus Obholzer; Nathalie Pochet; Clary B Clish; Marco Prinz; Alexandre Prat; Jack Antel; Francisco J Quintana
Journal:  Nat Med       Date:  2016-05-09       Impact factor: 53.440

View more
  29 in total

Review 1.  Control of immune-mediated pathology via the aryl hydrocarbon receptor.

Authors:  Michael A Wheeler; Veit Rothhammer; Francisco J Quintana
Journal:  J Biol Chem       Date:  2017-06-14       Impact factor: 5.157

2.  A gut feeling about multiple sclerosis.

Authors:  Francisco J Quintana; Marco Prinz
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-25       Impact factor: 11.205

Review 3.  Insights into study design and statistical analyses in translational microbiome studies.

Authors:  Jyoti Shankar
Journal:  Ann Transl Med       Date:  2017-06

4.  Tolerogenic nanoparticles suppress central nervous system inflammation.

Authors:  Jessica E Kenison; Aditi Jhaveri; Zhaorong Li; Nikita Khadse; Emily Tjon; Sara Tezza; Dominika Nowakowska; Agustin Plasencia; Vincent P Stanton; David H Sherr; Francisco J Quintana
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-25       Impact factor: 11.205

Review 5.  The impact of the gut microbiome on extra-intestinal autoimmune diseases.

Authors:  Eiji Miyauchi; Chikako Shimokawa; Alex Steimle; Mahesh S Desai; Hiroshi Ohno
Journal:  Nat Rev Immunol       Date:  2022-05-09       Impact factor: 53.106

6.  Variations in diet cause alterations in microbiota and metabolites that follow changes in disease severity in a multiple sclerosis model.

Authors:  J E Libbey; J M Sanchez; D J Doty; J T Sim; M F Cusick; J E Cox; K F Fischer; J L Round; R S Fujinami
Journal:  Benef Microbes       Date:  2018-01-30       Impact factor: 4.205

Review 7.  The Role of Astrocytes in CNS Inflammation.

Authors:  Federico Giovannoni; Francisco J Quintana
Journal:  Trends Immunol       Date:  2020-08-13       Impact factor: 16.687

Review 8.  The Gut-CNS Axis in Multiple Sclerosis.

Authors:  Atsushi Kadowaki; Francisco J Quintana
Journal:  Trends Neurosci       Date:  2020-07-07       Impact factor: 13.837

Review 9.  Microbiota Signaling Pathways that Influence Neurologic Disease.

Authors:  Laura M Cox; Howard L Weiner
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

Review 10.  Gut microbiome in multiple sclerosis: The players involved and the roles they play.

Authors:  Shailesh K Shahi; Samantha N Freedman; Ashutosh K Mangalam
Journal:  Gut Microbes       Date:  2017-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.